805O ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment.

Autor:	Clamp, A.R.1 (AUTHOR), James, E.C.2 (AUTHOR), McNeish, I.3 (AUTHOR), Dean, A.4 (AUTHOR), Kim, J-W.5 (AUTHOR), O'Donnell, D.M.6 (AUTHOR), Hook, J.7 (AUTHOR), Gallardo-Rincon, D.8 (AUTHOR), Coyle, C.2 (AUTHOR), Blagden, S.9 (AUTHOR), Brenton, J.D.10 (AUTHOR), Naik, R.11 (AUTHOR), Perren, T.J.12 (AUTHOR), Sundar, S.13 (AUTHOR), Cook, A.2 (AUTHOR), Badrock, J.2 (AUTHOR), Swart, A.M.14 (AUTHOR), Parmar, M.K.2 (AUTHOR), Kaplan, R.S.2 (AUTHOR), Ledermann, J.A.15 (AUTHOR)
Zdroj:	Annals of Oncology. 2020 Supplement 4, Vol. 31, pS610-S610. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu